MICHAEL DORWART: Open Payments
NPI 1225243892 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,194 in 38 payments from 10 companies in 2025. Trend: 2023 $217 · 2024 $603 · 2025 $1,194
Food & beverage: $746Travel & lodging: $448
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 6 | $523 |
| Medtronic, Inc. | 15 | $271 |
| ABBVIE INC. | 8 | $196 |
| Saluda Medical Americas, Inc. | 3 | $66 |
| BIOTRONIK NRO, Inc. | 1 | $43 |
| TerSera Therapeutics LLC | 1 | $26 |
| Tonix Medicines, Inc. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| MML US, Inc. | 1 | $8 |
Products named: PROCLAIM, SYNCHROMEDII, QULIPTA, BOTOX, Evoke, Prospera, INTELLIS ADAPTIVESTIM, INCEPTIV.
Industry payments across IN — which companies pay providers there.
